NovoCure Limited (NVCR)

NovoCure Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,047	1,595	7,698	7,795	17,615	8,340
Market Cap Growth	-58.18%	-79.27%	-1.24%	-55.75%	111.21%	167.82%
Enterprise Value	1,767	1,264	7,307	7,434	17,394	8,192
Last Close Price	17.13	14.93	73.35	75.08	173.04	84.27
PE Ratio	-	-7.66	-82.96	-133.09	961.33	-1133.38
PS Ratio	3.72	3.13	14.31	14.57	35.63	23.74
PB Ratio	5.66	4.40	17.45	18.99	36.97	38.29
P/FCF Ratio	-17.65	-15.89	816.34	133.05	209.25	516.89
P/OCF Ratio	-27.45	-21.76	250.04	94.19	177.66	313.30
EV/Sales Ratio	3.21	2.48	13.59	13.89	35.18	23.32
EV/EBITDA Ratio	-9.42	-5.84	-92.10	-215.30	451.06	1323.29
EV/EBIT Ratio	-8.89	-5.59	-82.19	-170.13	564.54	-13956.52
EV/FCF Ratio	-15.01	-12.59	774.90	126.89	206.62	507.75
Debt / Equity Ratio	1.87	1.67	1.32	1.40	0.93	0.75
Debt / EBITDA Ratio	-	-	-	-	9.98	14.10
Debt / FCF Ratio	-6.46	-6.02	61.97	9.82	5.28	10.14
Asset Turnover	0.46	0.44	0.46	0.49	0.65	0.86
Inventory Turnover	3.60	3.78	4.25	4.41	4.15	3.82
Quick Ratio	6.20	5.46	6.73	7.29	8.38	4.71
Current Ratio	6.46	5.78	7.00	7.53	8.80	5.10
Return on Equity (ROE)	-43.40%	-51.52%	-21.73%	-13.16%	5.71%	-4.38%
Return on Assets (ROA)	-9.30%	-12.09%	-4.77%	-2.49%	2.51%	-0.09%
Return on Capital (ROIC)	-10.80%	-14.19%	-5.53%	-2.86%	2.96%	-0.11%
Earnings Yield	-8.24%	-12.98%	-1.20%	-0.75%	0.11%	-0.09%
FCF Yield	-5.10%	-6.29%	0.12%	0.75%	0.48%	0.19%
Buyback Yield / Dilution	-1.33%	-1.65%	-1.19%	5.00%	-11.97%	-5.89%
Total Shareholder Return	-1.33%	-1.65%	-1.19%	5.00%	-11.97%	-5.89%

Source: S&P Capital IQ. Standard template.